Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitors

Bioorg Med Chem Lett. 2012 Jun 15;22(12):4127-32. doi: 10.1016/j.bmcl.2012.04.065. Epub 2012 Apr 20.

Abstract

A series of 2'-C-methyl branched purine and pyrimidine C-nucleosides were prepared. Their anti-HCV activity and pharmacological properties were profiled, and compared with known 2'-C-Me N-nucleoside counterparts. In particular, 2'-C-Me 4-aza-7,9-dideazaadenosine C-nucleoside (2) was found to have potent and selective anti-HCV activity in vitro as well as a favorable pharmacokinetic profile and in vivo potential for enhanced potency over the corresponding N-nucleoside.

MeSH terms

  • Administration, Oral
  • Animals
  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / pharmacokinetics
  • Antiviral Agents / pharmacology
  • Aza Compounds / chemical synthesis*
  • Aza Compounds / pharmacokinetics
  • Aza Compounds / pharmacology
  • Cell Line
  • Cricetinae
  • Dogs
  • Hepacivirus / drug effects*
  • Hepacivirus / enzymology
  • Hepacivirus / growth & development
  • Hepatocytes / drug effects
  • Hepatocytes / virology
  • Humans
  • Injections, Intravenous
  • Primary Cell Culture
  • Purine Nucleosides / chemical synthesis*
  • Purine Nucleosides / pharmacokinetics
  • Purine Nucleosides / pharmacology
  • Pyrimidine Nucleosides / chemical synthesis*
  • Pyrimidine Nucleosides / pharmacokinetics
  • Pyrimidine Nucleosides / pharmacology
  • RNA-Dependent RNA Polymerase / antagonists & inhibitors*
  • RNA-Dependent RNA Polymerase / metabolism
  • Rats
  • Viral Nonstructural Proteins / antagonists & inhibitors*
  • Viral Nonstructural Proteins / metabolism

Substances

  • Antiviral Agents
  • Aza Compounds
  • Purine Nucleosides
  • Pyrimidine Nucleosides
  • Viral Nonstructural Proteins
  • NS-5 protein, hepatitis C virus
  • RNA-Dependent RNA Polymerase